Abercrombie & Fitch Co. operates as a specialty retailer of all types of premium, high-quality casual apparel for men, women, and kids through a vast store network across N. America, Europe, Asia and the Middle East under the Abercrombie & Fitch, abercrombie kids and Hollister brands. Also, the company sells inner wear, personal care products, sleepwear and at-home products for girls through direct-to-consumer operations and Hollister stores under the Gilly Hicks brand. It also sells products through its e-commerce platform. Region-wise it reports its sales under two segments - U.S. Stores (U.S. and Puerto Rico) and International Stores (Canada, Europe, Asia, Australia and the Middle East). Brand-wise, Abercrombie reports in 2 segments - Abercrombie and Hollister. Abercrombie includes the Abercrombie & Fitch and abercrombie kids brands. Hollister is based on a South California theme, and targets youth in their late teens. Stores under this brand also offer intimate products of the Gilly Hicks brand....
+See More2019-10-17 08:35:00 Thursday ET

The European Central Bank expects to further reduce negative interest rates with new quantitative government bond purchases. The ECB commits to further cutt
2023-06-07 10:27:00 Wednesday ET

Anat Admati and Martin Hellwig raise broad critical issues about bank capital regulation and asset market stabilization. Anat Admati and Martin Hellwig (
2018-04-17 12:38:00 Tuesday ET

Value investment strategies make investors wiser like water with core fundamental factor analysis. Value investors tend to buy stocks below their intrinsic
2019-05-23 10:33:00 Thursday ET

Berkeley professor and economist Barry Eichengreen reconciles the nominal and real interest rates to argue in favor of greater fiscal deficits. French econo
2019-05-11 10:28:00 Saturday ET

The Trump administration still expects to reach a Sino-U.S. trade agreement with a better mechanism for intellectual property protection and enforcement. Pr
2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be